Jaysón Davidson is currently a Ph.D. candidate in the Pharmaceutical Sciences and Pharmacogenomics program at University of California San Francisco (UCSF). At UCSF, he is a member of Dr. Atul Butte’s lab, where he works with Electronic Health Records to answer questions in the context of clinical disease. In the lab, he intends to develop methods to effectively stratify the differences in disease and drug response outcomes between populations with different social determinants to improve overall healthcare quality and equity. Jaysón primarily studies treatment utilization, and health outcomes of Type 2 Diabetes patients that are treated within the UC-Health system. At UCSF, Jaysón has been selected as a UCSF-Stanford FDA CERSI Diversity scholar, NIGMS-IMSD program affiliate, and UCSF BE-STEM Co-president. Outside of UCSF, Jaysón is the social media chair and E-Board Member of BlackinChem 501(c)3. Alongside his accomplishments and leadership positions, he works diligently on developing collaborations to answer clinical questions that directly affects people in his community to help create more equitable healthcare quality & access. More importantly, Jaysón works on communicating his science in a way that is digestible so that the clinical importance of his research can be understand outside of the medical community.Prior to UCSF, Jaysón was a NIH-PREP post-baccalaureate scholar at Baylor College of Medicine (BCM) where he carried out a gene-editing project for the treatment of Catecholaminergic Ventricular Tachycardia (CPVT) in an animal model. Furthermore, Davidson's background includes research on structural studies of a short-chain reductase from a bacterium Paraburkholderia Xenovorans which resulted in a first-author publication at Hampton University where he earned his B.S. in Biochemistry. At Hampton University, Jaysón was intitiated into the Beta Chi Chapter of Kappa Alpha Psi Fraternity, Inc. while playing Division I football and leading the team as captain.